Roivant Sciences Ltd. · NASDAQ:ROIV
Gline Matthew had 358,510 Roivant Sciences Ltd. shares withheld for tax (Form 4)
Traded Mar 30 to Mar 31, 2026 · Filed Apr 1, 2026
From Mar 30 to Mar 31, 2026, Gline Matthew (Director, CEO) had 358,510 Roivant Sciences Ltd. shares withheld for tax at an average US$27.51 for US$9.86M, leaving 17,025,890 shares. Filed Apr 1, 2026 (Form 4).
- Withheld for tax
- 358,510 shares
- Price
- US$27.51 average (US$26.41 to US$27.70)
- Value
- US$9.86M
- Holding after
- 17,025,890 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Common Shares | Option exercise | 97,319 | 17,384,400 | Direct | |
| Mar 30, 2026 | Common Shares | Shares withheld for tax | 53,826 | US$26.41 | 17,330,574 | Direct |
| Mar 31, 2026 | Common Shares | Shares withheld for tax | 304,684 | US$27.70 | 17,025,890 | Direct |
Source
Related
- Roivant Sciences Ltd.
- Gline Matthew
- Roivant Sciences Ltd. shareholders
- Form 4 · Gline Matthew · Oct 2, 2026
- Form 4 · Gline Matthew · Jul 2, 2026
- Form 4 · Gline Matthew · Apr 20, 2026
- Form 4 · Epperly Melissa B, · Oct 5, 2026
- Form 4 · Sukhatme Mayukh · Oct 2, 2026
- Form 4 · Venker Eric · Oct 2, 2026
- Form 4 · Torti Frank · Oct 2, 2026
- Form 4 · Pulik Richard · Sep 22, 2026